(Q40616036)

22 September 2017

title

ACOG technology assessment. Genetics and molecular diagnostic testing. Number 1, July 2002. American College of Obstetrics and Gynecology (English)

1 reference

22 September 2017

author name string

American College of Obstetrics and Gynecology

series ordinal

1

1 reference

22 September 2017

publication date

1 October 2002

1 reference

International Journal of Gynecology and Obstetrics

22 September 2017

published in

1 reference

22 September 2017

volume

79

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

67-85

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

22 September 2017

1 reference

Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

A molecular variant of angiotensinogen associated with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Preeclampsia-associated hepatic hemorrhage and rupture: mode of management related to maternal and perinatal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Eclampsia. VIII. Risk factors for maternal morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Clinicopathological study of neurological complications due to hypertensive disorders of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Blindness associated with preeclampsia and eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Can antenatal clinical and biochemical markers predict the development of severe preeclampsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

The clinical utility of serum uric acid measurements in hypertensive diseases of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Hypertension in pregnancy: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Treatment of hypertension in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

The safety and utility of pulmonary artery catheterization in severe preeclampsia and eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Preeclampsia prevention: lessons from the low-dose aspirin therapy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Does gestational hypertension become pre-eclampsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Evaluation of a definition of pre-eclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Should the definition of preeclampsia include a rise in diastolic blood pressure of >/=15 mm Hg to a level <90 mm Hg in association with proteinuria?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Correlation between placental bed biopsy findings, vascular cell adhesion molecule and fibronectin levels in pre-eclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Longitudinal evaluation of hemodynamic changes in eclampsia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Hepatic hemorrhage without rupture in preeclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Prediction of pre-eclampsia, low birthweight for gestation and prematurity by uterine artery blood flow velocity waveforms analysis in low risk nulliparous women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

A protocol for managing severe preeclampsia in the second trimester

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Severe preeclampsia remote from term: labor induction or elective cesarean delivery?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Antihypertensive therapy in pregnancy directed by noninvasive hemodynamic monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Prevention of preeclampsia: a big disappointment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Trial of calcium to prevent preeclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0020-7292(02)80002-9

1 reference

22 September 2017

1 reference